Gentherapie in de urologie

Translated title of the contribution: Gene therapy in urology

C. H. Bangma, P. Mulders, W. Gerritsen

Research output: Contribution to journalArticle

Abstract

The aim of gene therapy is to introduce genetic information into target cells, in order to use the cell machinery for the production of the gene product. This might be used to correct for defecient genes and restore normal function, or to destroy cells by cytopathic or immunologic mechanisms. The vehicles used to introduce genes are called 'vectors'. For cancer therapy in experimental and clinical settings, attenuated adenoviruses are used. Urologic applications in The Netherlands are discussed.

Original languageDutch
Pages (from-to)31-33
Number of pages3
JournalNederlands Tijdschrift voor Urologie
Volume9
Issue number2
StatePublished - 2001
Externally publishedYes

Fingerprint

Urology
Genetic Therapy
Genes
Investigational Therapies
Adenoviridae
Netherlands
Neoplasms

ASJC Scopus subject areas

  • Urology

Cite this

Bangma, C. H., Mulders, P., & Gerritsen, W. (2001). Gentherapie in de urologie. Nederlands Tijdschrift voor Urologie, 9(2), 31-33.

Gentherapie in de urologie. / Bangma, C. H.; Mulders, P.; Gerritsen, W.

In: Nederlands Tijdschrift voor Urologie, Vol. 9, No. 2, 2001, p. 31-33.

Research output: Contribution to journalArticle

Bangma, CH, Mulders, P & Gerritsen, W 2001, 'Gentherapie in de urologie', Nederlands Tijdschrift voor Urologie, vol. 9, no. 2, pp. 31-33.
Bangma CH, Mulders P, Gerritsen W. Gentherapie in de urologie. Nederlands Tijdschrift voor Urologie. 2001;9(2):31-33.
Bangma, C. H. ; Mulders, P. ; Gerritsen, W. / Gentherapie in de urologie. In: Nederlands Tijdschrift voor Urologie. 2001 ; Vol. 9, No. 2. pp. 31-33.
@article{f9d28b4a85a147ef810fdb76d17519d6,
title = "Gentherapie in de urologie",
abstract = "The aim of gene therapy is to introduce genetic information into target cells, in order to use the cell machinery for the production of the gene product. This might be used to correct for defecient genes and restore normal function, or to destroy cells by cytopathic or immunologic mechanisms. The vehicles used to introduce genes are called 'vectors'. For cancer therapy in experimental and clinical settings, attenuated adenoviruses are used. Urologic applications in The Netherlands are discussed.",
author = "Bangma, {C. H.} and P. Mulders and W. Gerritsen",
year = "2001",
language = "Dutch",
volume = "9",
pages = "31--33",
journal = "Nederlands Tijdschrift voor Urologie",
issn = "0929-0184",
publisher = "Elsevier Bedrijfsinformatie bv",
number = "2",

}

TY - JOUR

T1 - Gentherapie in de urologie

AU - Bangma, C. H.

AU - Mulders, P.

AU - Gerritsen, W.

PY - 2001

Y1 - 2001

N2 - The aim of gene therapy is to introduce genetic information into target cells, in order to use the cell machinery for the production of the gene product. This might be used to correct for defecient genes and restore normal function, or to destroy cells by cytopathic or immunologic mechanisms. The vehicles used to introduce genes are called 'vectors'. For cancer therapy in experimental and clinical settings, attenuated adenoviruses are used. Urologic applications in The Netherlands are discussed.

AB - The aim of gene therapy is to introduce genetic information into target cells, in order to use the cell machinery for the production of the gene product. This might be used to correct for defecient genes and restore normal function, or to destroy cells by cytopathic or immunologic mechanisms. The vehicles used to introduce genes are called 'vectors'. For cancer therapy in experimental and clinical settings, attenuated adenoviruses are used. Urologic applications in The Netherlands are discussed.

UR - http://www.scopus.com/inward/record.url?scp=0035652893&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035652893&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0035652893

VL - 9

SP - 31

EP - 33

JO - Nederlands Tijdschrift voor Urologie

JF - Nederlands Tijdschrift voor Urologie

SN - 0929-0184

IS - 2

ER -